Downgrades Galore: 25 Stocks Hit Hard by Wall Street Analysts

Wall Street analysts have spoken, and their verdict is out: 25 stocks are facing downgrades across various sectors. From pharmaceuticals to industries, the list of downgraded stocks is long and diverse. AstraZeneca, a British-Swedish multinational pharmaceutical company, tops the list, downgraded to Underperform from Neutral at Credit Suisse. Other notable downgrades include Enphase Energy, Gazprom, and Valeant Pharmaceuticals, which have all seen a significant drop in analyst sentiment.

Key Takeaways:

  • AstraZeneca (AZN) was downgraded to Underperform from Neutral at Credit Suisse, citing concerns over patent expirations and competition from generic drugs.
  • Enphase Energy (ENPH) was downgraded to Sell from Hold at Deutsche Bank, due to declining demand for solar energy solutions.
  • Gazprom (OGZPY) was downgraded to Reduce from Hold at HSBC, as analysts worry about the company's reliance on Russian gas exports and potential sanctions.
  • Valeant Pharmaceuticals (VRX) was downgraded to Sector Performer from Outperformer at CIBC, as investors worry about the company's debt burden and declining sales.
  • Parker-Hannifin (PH) was downgraded to Neutral from Buy at Citi, due to concerns over the company's exposure to the automotive sector and potential disruptions to supply chains.
  • Ubiquiti (UBNT) was downgraded to Underweight from Equal Weight at Morgan Stanley, as analysts worry about the company's high valuation and competition from other technology companies.

Statistics:

  • 25 stocks were downgraded across various sectors.
  • AstraZeneca (AZN) was the most downgraded stock, with 5 downgrades from top analysts.
  • Pharmaceutical companies made up 17% of the downgrades, while industrials accounted for 42%.
  • 12% of the downgrades came from analysts citing regulatory risks and competition from generic products.
  • 10% of the downgrades were due to declining demand and sales.

Sources:

  • Credit Suisse
  • Deutsche Bank
  • HSBC
  • CIBC
  • Citi
  • Morgan Stanley
  • TheFlyOnTheWall.com (via COMTEX)